Skip to main content
. 2019 Feb 28;9:3011. doi: 10.1038/s41598-019-39925-5

Figure 4.

Figure 4

Overall and individual study estimates of the RR of major bleeding associated with NOACs treatment vs. VKAs treatment in all studies (a) and in the randomized controlled studies (b). Parallelogram boxes denote the RR, and horizontal lines represent 95% confidence intervals. RR = Risk Ratio, NOACs = non-vitamin K antagonist oral anticoagulants, VKAs = vitamin K antagonists.